Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2009
  • Online publication date: July 2009

7 - Neuropsychiatric features of dementia

Summary

Introduction

Neuropsychiatric symptoms are a common problem in dementia. Epidemiological studies indicate that approximately 60% of demented subjects in the community exhibit some degree of psychopathology. Among specific populations of subjects diagnosed with frontotemporal dementia (FTD) or advanced Alzheimer's disease (AD), the prevalence of behavioral pathology increases to 95%. The most frequently reported behavioral symptoms include apathy, agitation and depression.

The significant contributions of neuropsychiatric symptoms to the more common dementia syndromes are reflected by their prominent role in the diagnosis of these conditions. Behavioral symptoms are primary components of the diagnostic criteria for FTD and dementia with Lewy bodies (DLB) and are among the secondary supportive factors in the diagnostic criteria for AD and vascular dementia (VaD). Disturbances in behavior have also been reported in mild cognitive impairment (MCI), Parkinson's disease with dementia (PDD), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD).

While the severity of a dementing illness is often determined using cognitive criteria, behavioral disturbances are responsible for a substantial proportion of the morbidity caused by different dementia syndromes. Caregivers for patients with dementia find behavioral abnormalities significantly more troubling than cognitive deficits. The presence of neuropsychiatric symptoms correlates with increased rates of institutionalization, cost of care and caregiver stress and burden.

The behavioral disruptions seen in dementia are not simply an inevitable consequence of worsening cognitive impairment. Although neuropsychiatric symptoms are often seen with greater frequency and severity in the later stages of dementing illnesses, the clinical course of different behavioral symptoms is often heterogeneous and does not correlate closely with the severity of cognitive or functional impairment.

Related content

Powered by UNSILO
References
Lyketsos, CG, Steinberg, M, Tschanz, JTet al. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. American Journal of Psychiatry 2000;157(5):708–14.
Mega, MS, Cummings, JL, Fiorello, T, Gornbein, J. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996;46(1):130–5.
Liu, W, Miller, BL, Kramer, JHet al. Behavioral disorders in the frontal and temporal variants of frontotemporal dementia. Neurology 2004;62(5):742–8.
Neary, D, Snowden, JS, Gustafson, Let al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51(6):1546–54.
McKeith, IG, Dickson, DW, Lowe, Jet al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65(12):1863–72.
McKhann, G, Drachman, D, Folstein, Met al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS–ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34(7):939–44.
Roman, GC, Tatemichi, TK, Erkinjuntti, Tet al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS–AIREN International Workshop. Neurology 1993;43(2):250–60.
Hwang, TJ, Masterman, DL, Ortiz, F, Fairbanks, , Cummings, JL. Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alzheimer Disease and Associated Disorders 2004;18(1):17–21.
Aarsland, D, Cummings, JL, Larsen, JP. Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease. International Journal of Geriatric Psychiatry 2001;16(2):184–91.
Litvan, I, Mega, MS, Cummings, JL, Fairbanks, L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 1996;47(5):1184–9.
Litvan, I, Cummings, JL, Mega, M. Neuropsychiatric features of corticobasal degeneration. Journal of Neurology, Neurosurgery and Psychiatry 1998; 65(5):717–21.
Deimling, GT, Bass, DM. Symptoms of mental impairment among elderly adults and their effects on family caregivers. Journal of Gerontology 1986; 41(6):778–84.
Yaffe, K, Fox, P, Newcomer, Ret al. Patient and caregiver characteristics and nursing home placement in patients with dementia. Journal of the American Medical Association 2002; 287(16):2090–7.
Beeri, MS, Werner, P, Davidson, M, Noy, S. The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients. International Journal of Geriatric Psychiatry 2002;17(5):403–8.
Coen, RF, Swanwick, GR, O'Boyle, CA, Coakley, D. Behaviour disturbance and other predictors of carer burden in Alzheimer's disease. International Journal of Geriatric Psychiatry 1997;12(3):331–6.
Mourik, JC, Rosso, SM, Niermeijer, MF, Duivenvoorden, HJ, Swieten, JC, Tibben, A. Frontotemporal dementia: behavioral symptoms and caregiver distress. Dementia Geriatric Cognitive Disorders 2004;18(3–4): 299–306.
Marin, DB, Green, CR, Schmeidler, Jet al. Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms. Journal of the American Geriatrics Society 1997;45(11):1331–8.
Tractenberg, RE, Weiner, MF, Cummings, JL, Patterson, MB, Thal, LJ. Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach. Journal of Neuropsychiatry and Clinical Neurosciences 2005;17(1):51–60.
Levy, ML, Cummings, JL, Fairbanks, et al. Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. American Journal of Psychiatry 1996;153(11):1438–43.
Hirono, N, Mori, E, Ishii, Ket al. Frontal lobe hypometabolism and depression in Alzheimer's disease. Neurology 1998;50(2):380–3.
Tekin, S, Mega, MS, Masterman, DMet al. Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Annals of Neurology 2001;49(3):355–61.
Hamilton, M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960;23:56–62.
Cohen-Mansfield, J. Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated. Journal of the American Geriatric Society 1986;34(10):722–7.
Alexopoulos, GS, Abrams, RC, Young, RC, Shamoian, CA. Cornell Scale for Depression in Dementia. Biological Psychiatry 1988;23(3):271–84.
Robert, PH, Clairet, S, Benoit, Met al. The Apathy Inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease, and mild cognitive impairment. International Journal of Geriatric Psychiatry 2002;17:1099–105.
Reisberg, B, Borenstein, J, Salob, SPet al. Behavioral symptoms in Alzheimer's disease phenomenology and treatment. Journal of Clinical Psychiatry 1987;48(Suppl):9–15.
Cummings, JL, Mega, M, Gray, Ket al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44(12):2308–14.
Cummings, JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 1997;48(Suppl 6):S10–16.
Mack, JL, Patterson, MB, Tariot, PN. Behavior Rating Scale for Dementia: development of test scales and presentation of data for 555 individuals with Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology 1999;12(4):211–23.
McShane, RH. What are the syndromes of behavioral and psychological symptoms of dementia?International Psychogeriatrics 2000;12(Suppl 1):147.
Burns, A, Folstein, S, Brandt, J, Folstein, M. Clinical assessment of irritability, aggression, and apathy in Huntington and Alzheimer disease. Journal of Nervous and Mental Disease 1990;178(1):20–6.
Hirono, N, Mori, E, Tanimukai, Set al. Distinctive neurobehavioral features among neurodegenerative dementias. Journal of Neuropsychiatry and Clinical Neurosciences 1999;11(4):498–503.
Aarsland, D, Litvan, I, Larsen, JP. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. Journal of Neuropsychiatry and Clinical Neurosciences 2001;13(1):42–9.
Kuhn, DR, Greiner, D, Arseneau, L. Addressing hypersexuality in Alzheimer's disease. Journal of Gerontological Nursing 1998;24(4):44–50.
Mendez, MF, Chen, AK, Shapira, JS, Miller, BL. Acquired sociopathy and frontotemporal dementia. Dementia and Geriatric Cognitive Disorders 2005;20(2–3):99–104.
Senanarong, V, Cummings, JL, Fairbanks, Let al. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction. Dementia and Geriatric Cognitive Disorders 2004;17(1–2):14–20.
Sultzer, DL, Mahler, ME, Mandelkern, MAet al. The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease. Journal of Neuropsychiatry and Clinical Neurosciences 1995;7(4):476–84.
Hirono, N, Mega, MS, Dinov, ID, Mishkin, F, Cummings, JL. Left frontotemporal hypoperfusion is associated with aggression in patients with dementia. Archives of Neurology 2000;57(6):861–6.
Franceschi, M, Anchisi, D, Pelati, Oet al. Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration. Annals of Neurology 2005;57(2):216–25.
Mendez, MF, McMurtray, A, Chen, AKet al. Functional neuroimaging and presenting psychiatric features in frontotemporal dementia. Journal of Neurology, Neurosurgery and Psychiatry 2006;77(1):4–7.
Chemerinski, E, Petracca, G, Sabe, L, Kremer, J, Starkstein, SE. The specificity of depressive symptoms in patients with Alzheimer's disease. American Journal of Psychiatry 2001;158(1):68–72.
Lyketsos, CG, Lee, HB. Diagnosis and treatment of depression in Alzheimer's disease. A practical update for the clinician. Dementia and Geriatric Cognitive Disorders 2004;17(1–2):55–64.
Katz, IR. Diagnosis and treatment of depression in patients with Alzheimer's disease and other dementias. Journal of Clinical Psychiatry 1998;59(Suppl 9):38–44.
Olin, JT, Schneider, LS, Katz, IRet al. Provisional diagnostic criteria for depression of Alzheimer disease. American Journal of Geriatric Psychiatry 2002;10(2):125–8.
Ferretti, L, McCurry, SM, Logsdon, R, Gibbons, L, Teri, L. Anxiety and Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology 2001;14(1):52–8.
Reisberg, B, Auer, SR, Monteiro, I, Boksay, I, Sclan, SG. Behavioral disturbances of dementia: an overview of phenomenology and methodologic concerns. International Psychogeriatrics 1996;8(Suppl 2):169–80; discussion 181–2.
Fuh, JL, Liu, CK, Mega, MS, Wang, SJ, Cummings, JL. Behavioral disorders and caregivers' reaction in Taiwanese patients with Alzheimer's disease. International Psychogeriatrics 2001;13(1):121–8.
Zubenko, GS. Clinicopathologic and neurochemical correlates of major depression and psychosis in primary dementia. International Psychogeriatrics 1996;8(Suppl 3):219–23; discussion 269–72.
Starkstein, SE, Petracca, G, Chemerinski, E, Kremer, J. Syndromic validity of apathy in Alzheimer's disease. American Journal of Psychiatry 2001;158(6):872–7.
Landes, AM, Sperry, SD, Strauss, ME, Geldmacher, DS. Apathy in Alzheimer's disease. Journal of the American Geriatric Society 2001;49(12):1700–7.
Craig, AH, Cummings, JL, Fairbanks, Let al. Cerebral blood flow correlates of apathy in Alzheimer disease. Archives of Neurology 1996;53(11):1116–20.
Benoit, M, Koulibaly, PM, Migneco, Oet al. Brain perfusion in Alzheimer's disease with and without apathy: a SPECT study with statistical parametric mapping analysis. Psychiatry Research 2002;114(2):103–11.
McMurtray, AM, Chen, AK, Shapira, JSet al. Variations in regional SPECT hypoperfusion and clinical features in frontotemporal dementia. Neurology 2006;66:517–22.
Benoit, M, Clairet, S, Koulibaly, PM, Darcourt, J, Robert, PH. Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's disease. International Journal of Geriatric Psychiatry 2004;19(9):864–9.
Marshall, GA, Fairbanks, , Tekin, S, Vinters, HV, Cummings, JL. Neuropathologic correlates of apathy in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2006;21(3):144–7.
Algase, DL. Wandering in dementia. Annual Review of Nursing Research 1999;17:185–217.
Nyatsanza, S, Shetty, T, Gregory, Cet al. A study of stereotypic behaviours in Alzheimer's disease and frontal and temporal variant frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry 2003;74(10):1398–402.
Rolland, Y, Payoux, P, Lauwers-Cances, Vet al. A SPECT study of wandering behavior in Alzheimer's disease. International Journal of Geriatric Psychiatry 2005;20(9):816–20.
Simard, M, Reekum, R, Cohen, T. A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. Journal of Neuropsychiatry and Clinical Neurosciences 2000;12(4):425–50.
Sultzer, DL. Psychosis and antipsychotic medications in Alzheimer's disease: clinical management and research perspectives. Dementia and Geriatric Cognitive Disorders 2004;17(1–2):78–90.
Mosimann, UP, Rowan, EN, Partington, CEet al. Characteristics of visual hallucinations in Parkinson disease dementia and dementia with Lewy bodies. American Journal of Geriatric Psychiatry 2006;14(2):153–60.
Mega, MS, Lee, L, Dinov, IDet al. Cerebral correlates of psychotic symptoms in Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 2000;69(2):167–71.
Kotrla, KJ, Chacko, RC, Harper, RG, Jhingran, S, Doody, R. SPECT findings on psychosis in Alzheimer's disease. American Journal of Psychiatry 1995;152(10):1470–5.
Pasquier, J, Michel, BF, Brenot-Rossi, Iet al. Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies. European Journal of Nuclear Medicine and Molecular Imaging 2002;29(10):1342–8.
O'Brien, JT, Firbank, MJ, Mosimann, UP, Burn, DJ, McKeith, IG. Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies. Psychiatry Research 2005;139(2):79–88.
Starkstein, SE, Vazquez, S, Petracca, Get al. A SPECT study of delusions in Alzheimer's disease. Neurology 1994;44(11):2055–9.
Mentis, MJ, Weinstein, EA, Horwitz, Bet al. Abnormal brain glucose metabolism in the delusional misidentification syndromes: a positron emission tomography study in Alzheimer disease. Biological Psychiatry 1995;38(7):438–49.
Staff, RT, Venneri, A, Gemmell, HGet al. HMPAO SPECT imaging of Alzheimer's disease patients with similar content-specific autobiographic delusion: comparison using statistical parametric mapping. Journal of Nuclear Medicine 2000;41(9):1451–5.
Perry, EK, McKeith, I, Thompson, Pet al. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Annals of the New York Academy of Sciences 1991;640:197–202.
Zubenko, GS, Moossy, J, Martinez, AJet al. Neuropathologic and neurochemical correlates of psychosis in primary dementia. Archives of Neurology 1991;48(6):619–24.
Forstl, H, Burns, A, Levy, R, Cairns, N. Neuropathological correlates of psychotic phenomena in confirmed Alzheimer's disease. British Journal of Psychiatry 1994;165(2):53–9.
Harding, AJ, Broe, GA, Halliday, GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002;125(Pt 2):391–403.
Lyketsos, CG, Corazzini, K, Steele, C. Mania in Alzheimer's disease. Journal of Neuropsychiatry and Clinical Neurosciences 1995;7(3):350–2.
Depp, CA, Jeste, DV. Bipolar disorder in older adults: a critical review. Bipolar Disorders 2004;6(5):343–67.
Gafoor, R, O'Keane, V. Three case reports of secondary mania: evidence supporting a right frontotemporal locus. European Psychiatry 2003;18(1):32–3.
Claggett, MS. Nutritional factors relevant to Alzheimer's disease. Journal of the American Dietetic Association 1989;89(3):392–6.
Snowden, JS, Bathgate, D, Varma, Aet al. Distinct behavioural profiles in frontotemporal dementia and semantic dementia. Journal of Neurology, Neurosurgery, and Psychiatry 2001;70(3):323–32.
Bliwise, DL. Sleep disorders in Alzheimer's disease and other dementias. Clinical Cornerstone 2004;6(Suppl 1A):S16–28.
Vitiello, MV, Prinz, PN. Alzheimer's disease. Sleep and sleep/wake patterns. Clinics in Geriatric Medicine 1989;5(2):289–99.
Boeve, BF, Silber, MH, Ferman, TJ, Lucas, JA, Parisi, JE. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Movement Disorders 2001;16(4):622–30.
Reisberg, B, Franssen, E, Sclan, SG, Kluger, A, Ferris, SH. Stage specific incidence of potentially remediable behavioral symptoms in aging and Alzheimer disease. Bulletin of Clinical Neurosciences 1989;54:95–112.
Sultzer, DL, Levin, HS, Mahler, ME, High, WM, Cummings, JL. A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. American Journal of Psychiatry 1993;150(12):1806–12.
Aharon-Peretz, J, Kliot, D, Tomer, R. Behavioral differences between white matter lacunar dementia and Alzheimer's disease: a comparison on the neuropsychiatric inventory. Dementia and Geriatric Cognitive Disorders 2000;11(5):294–8.
Fuh, JL, Wang, SJ, Cummings, JL. Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia. Journal of Neurology, Neurosurgery and Psychiatry 2005;76(10):1337–41.
Ikeda, M, Fukuhara, R, Shigenobu, Ket al. Dementia associated mental and behavioural disturbances in elderly people in the community: findings from the first Nakayama study. Journal of Neurology, Neurosurgery and Psychiatry 2004;75(1):146–8.
Srikanth, S, Nagaraja, AV, Ratnavalli, E. Neuropsychiatric symptoms in dementia: frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia. Journal of the Neurological Sciences 2005;236(1–2):43–8.
Kales, HC, Maixner, DF, Mellow, AM. Cerebrovascular disease and late-life depression. American Journal of Geriatric Psychiatry 2005;13(2):88–98.
Gorno-Tempini, ML, Dronkers, NF, Rankin, KPet al. Cognition and anatomy in three variants of primary progressive aphasia. Annals of Neurology 2004;55(3):335–46.
Mendez, MF, Perryman, KM, Miller, BL, Cummings, JL. Behavioral differences between frontotemporal dementia and Alzheimer's disease: a comparison on the BEHAVE-AD rating scale. International Psychogeriatrics 1998;10(2):155–62.
Bozeat, S, Gregory, CA, Ralph, MA, Hodges, JR. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease?Journal of Neurology, Neurosurgery and Psychiatry 2000;69(2):178–86.
Marczinski, CA, Davidson, W, Kertesz, A. A longitudinal study of behavior in frontotemporal dementia and primary progressive aphasia. Cognitive and Behavioral Neurology 2004;17(4):185–90.
Aarsland, D, Ballard, C, Larsen, JP, McKeith, I. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. International Journal of Geriatric Psychiatry 2001;16(5):528–36.
Boxer, AL, Geschwind, MD, Belfor, Net al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Archives of Neurology 2006;63(1):81–6.
Cohen-Mansfield, J. Use of patient characteristics to determine nonpharmacologic interventions for behavioral and psychological symptoms of dementia. International Psychogeriatrics 2000;12 (Suppl 1):373–80.
Teri, L. Combined therapy: a research overview. International Psychogeriatrics 2000;12(Suppl 1):381–6.
Cohen-Mansfield, J. Nonpharmacologic interventions for inappropriate behaviors in dementia: a review, summary, and critique. American Journal of Geriatric Psychiatry 2001;9(4):361–81.
Emre, M, Aarsland, D, Albanese, Aet al. Rivastigmine for dementia associated with Parkinson's disease. New England Journal of Medicine 2004;351(24):2509–18.
Sink, KM, Holden, KF, Yaffe, K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. Journal of the American Medical Association 2005;293(5):596–608.
Wynn, ZJ, Cummings, JL. Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2004;17(1–2):100–8.
Gauthier, S, Wirth, Y, Mobius, HJ. Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies. International Journal of Geriatric Psychiatry 2005;20(5):459–64.
Taragano, FE, Lyketsos, CG, Mangone, CA, Allegri, RF, Comesana-Diaz, E. A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer's disease. Psychosomatics 1997;38(3):246–52.
Katona, CL, Hunter, BN, Bray, J. A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia. International Journal of Geriatric Psychiatry 1998;13(2):100–8.
Huey, ED, Putnam, KT, Grafman, J. A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology 2006;66(1):17–22.
Schneider, LS, Dagerman, KS, Insel, P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. Journal of the American Medical Association 2005;294(15):1934–43.
US Food and Drug Administration. FDA Public Health Advisory: deaths with antipsychotics in elderly patients with behavioral disturbances. Washington, DC: US Food and Drug Administration. http://www.fda.gov/cder/rug/advisory/antipsychotics.htm (accessed March 3, 2006).
Wang, PS, Schneeweiss, S, Avorn, Jet al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. New England Journal of Medicine 2005;353(22):2335–41.